Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

336.74 +0.74 (+0.22%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk ↗

July 01, 2025

Via The Motley Fool

Why Amgen Stock Popped by 4% Today ↗

July 01, 2025

Via The Motley Fool

Dogs Of The Dow: How You Can Get Dividend Stocks With Yields Up To 6.3% ↗

July 01, 2025

The Dow Jones Industrial Average stocks average a 2% dividend yield through the first six months of 2025. Here are the top yields.

Via Benzinga

Topics Stocks

Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment? ↗

June 30, 2025

The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.

Via Investor's Business Daily

Is Amgen Stock a Buy? ↗

May 29, 2025

Via The Motley Fool

Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects ↗

June 30, 2025

Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected later.

Via Benzinga

Amgen’s Cancer Drug Improves Survival In Late-stage Trial ↗

June 30, 2025

Bemarituzumab plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival as compared to placebo plus chemotherapy in the trial.

Via Stocktwits

Topics Death

2 Dividend Stocks to Buy on the Dip and Hold Forever ↗

June 30, 2025

Via The Motley Fool

Topics Government Stocks World Trade

Where Amgen Stands With Analysts ↗

June 24, 2025

Via Benzinga

Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues ↗

June 24, 2025

Amgen's MariTide showed strong weight loss and metabolic gains in Phase 2, with no new safety signals as Phase 3 trials begin in obesity and T2D.

Via Benzinga

Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update ↗

June 23, 2025

Amgen shares are trading lower Monday afternoon. The company released full results from part one of its phase two study of MariTide.

Via Benzinga

Uncover the latest developments among S&P500 stocks in today's session. ↗

June 23, 2025

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Via Chartmill

Amgen Expands Development Plans For Highly Anticipated Obesity Drug ↗

June 23, 2025

Amgen is expanding its plans for weight-loss drug, MariTide, with a trio of upcoming Phase 3 studies.

Via Investor's Business Daily

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗

June 20, 2025

A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.

Via Benzinga

2 Large-Cap Stocks to Consider Right Now and 1 to Steer Clear Of

June 20, 2025

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for...

Via StockStory

Topics Economy

Amgen Options Trading: A Deep Dive into Market Sentiment ↗

June 18, 2025

Via Benzinga

Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Bills ↗

June 17, 2025

The Democratic lawmakers alleged that pharmaceutical companies avoided paying U.S. tax bills by shifting their profits to offshore subsidiaries in jurisdictions with significantly lower tax rates, such...

Via Stocktwits

Topics Government

Members of Congress Are Pouring Millions Into These 7 Surprising Stocks ↗

June 17, 2025

Via The Motley Fool

Upstream Bio Stock Gets A Boost As New Lung Inflammation Drug Shows Higher Potency ↗

June 15, 2025

The company is progressing with multiple Phase 2 trials for its investigational treatment targeting severe respiratory diseases.

Via Stocktwits

Unpacking the Latest Options Trading Trends in Amgen ↗

June 09, 2025

Via Benzinga

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching. ↗

June 06, 2025

Amgen is hoping to take on Eli Lilly and Novo Nordisk with a potential monthly shot, MariTide.

Via Investor's Business Daily

2 Dividend Growth Stocks to Buy and Hold Forever ↗

June 06, 2025

Via The Motley Fool

Topics Intellectual Property

1 S&P 500 Stock to Consider Right Now and 2 to Steer Clear Of

June 04, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Amgen Says Its Drug Reduces Risk Of Death By 40% In Small Cell Lung Cancer: Retail’s Yet To Be Convinced ↗

June 02, 2025

The company also stated that the interim data from the trial showed the therapy significantly extended median overall survival by more than five months.

Via Stocktwits

3 No-Brainer Healthcare Stocks to Buy in June ↗

June 02, 2025

Via The Motley Fool

2 Dow Jones Stocks with Promising Prospects and 1 to Avoid

May 29, 2025

The Dow Jones (^DJI) is made up of 30 of the most established and influential companies in the market. But even blue-chip stocks can struggle - some are dealing with slowing growth, outdated business...

Via StockStory

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

May 28, 2025

Via Benzinga

The Promise of Quantum Computing ↗

May 27, 2025

The race to quantum supremacy is on. While this future will not come tomorrow, big tech companies are building to the technology's "ChatGPT moment."

Via The Motley Fool

Topics Artificial Intelligence

"If Walmart Is Under Pressure to Raise Prices, It's Going to Have Broader Effects on the Economy." ↗

May 27, 2025

Via The Motley Fool

Topics Earnings Economy World Trade

The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now ↗

May 24, 2025

Via The Motley Fool

Topics Economy Stocks World Trade

< Previous 1 2 3 4 5 6 7 8 9

...

60 61 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.